SGEM#76: And the Beat Goes On (Azithromycin and Risk of Cardiovascular Death)

Studien extrahiert aus dem Podcast von Dr. Ken Milne

• 2012Azithromycin and the Risk of Cardiovascular DeathElectrophysiology & AFIn 3.5 million Medicaid courses in adults aged 30-74, azithromycin raised cardiovascular death over 5 days compared with amoxicillin or no antibiotics.
• 2013Use of Azithromycin and Death from Cardiovascular CausesElectrophysiology & AFIn over 8 million antibiotic treatment episodes in Danish adults aged 18-64,azithromycindid not increasecardiovascular deathcompared withpenicillin V